• $7,077.00
    Market Cap
  • -98.95%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 31
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.0001
$0.0001
$0.0001
1-Year Range
$0.0001
$0.01
$0.0001
Latest Close$0.0001
Change
$0.00 (0.00%)
Volume500
Market Cap$7,077.00
Shares Outstanding70.8M
P/E (TTM)-0.04
Diluted EPS (TTM)-$0.003
Enterprise Value$158,792.00

Information as of 06/01/2026

Company Profile

NEXIEN BIOPHARMA, INC.
https://www.nexienbiopharma.com
$7,077.00
Market Cap
-$188,082.00
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
4340 East Kentucky Avenue, Glendale, CO, United States, 80246
303 495 7583

Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions in the United States. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.

Key Executives

  • Robert I. Goldfarb
  • Richard S. Greenberg
  • Evan L. Wasoff

Current Ownership Distribution

  • Insiders89.5M (37.80%)
  • Institutions83.2M (35.11%)
  • Mutual Funds64.2M (27.09%)
  • Other0 (0.00%)